SCHEMBL7219067

SCHEMBL7219067

O=C(NCc1ccc(Cl)cc1Cl)c1ccnnc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP1 P29466 1/20 0.64
▸ TSHR P16473 1/20 0.57
▸ EPHX2 P34913 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ NLRP1 Q9C000 1/20 0.51
▸ HPGD P15428 1/20 0.50
▸ MAPT P10636 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ P2RX7 Q99572 3/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ ERCC1 P07992 1/20 0.44
▸ ERCC4 Q92889 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30277756 0.78 CASP1 (1.00) CASP1TSHREPHX2LMNAMAPK1
SCHEMBL5899679 0.78 CASP1 (0.72) CASP1TSHREPHX2LMNAMAPK1
SCHEMBL5899792 0.78 CASP1 (1.00) CASP1TSHREPHX2LMNAMAPK1
SCHEMBL23675382 0.76 ERCC1 (0.59) CASP1TSHREPHX2LMNAMAPK1
SCHEMBL6357794 0.76 TSHR (0.64) CASP1TSHREPHX2LMNAMAPK1
SCHEMBL30100395 0.76 ERCC1 (0.59) CASP1TSHREPHX2LMNAMAPK1
SCHEMBL30277741 0.76 CASP1 (0.75) CASP1TSHREPHX2LMNAMAPK1
SCHEMBL6356112 0.74 TSHR (0.58) CASP1TSHREPHX2LMNAMAPK1
SCHEMBL5643784 0.73 TSHR (0.60) CASP1TSHREPHX2LMNAMAPK1
SCHEMBL8309693 0.73 CA12 (0.44) CASP1HPGDMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6624166-B1 Pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1 beta protease activity in a mammal utilizing the compounds and compositions for enzyme inhibitors VERTEX PHARMACEUTICALS INCORPORATED 2003-09-23 — — US claimed
Send feedback